X4 Pharma founder Renato Skerlj signs on as its R&D chief by Amirah Al Idrus Wednesday, September 18, 2019 X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.
Acceleron dumps dalantercept after kidney cancer trial fail by Nick Paul Taylor Tuesday, June 13, 2017 Acceleron Pharma has jettisoned dalantercept after the inhibitor of ALK1 signaling failed to move the needle in a phase 2 kidney cancer trial.
